Clinical Trial Update: Phase IV Clinical Trial (STAR Study) Extension Study of Conbercept Ophthalmic Injection for Treatment of Polypoid Choroidal Vasculopathy [Phase 4]

View source ↗

Summary

Phase IV extension study (STAR Study) of Conbercept ophthalmic injection for polypoidal choroidal vasculopathy is underway, with the current status not specifie…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Conbercept (conbercept)

Snippet

Sponsor: Chengdu Kanghong Biotech Co., Ltd. | Conditions: Polypoid Choroidal Vasculopathy (PCV) | Phase 4 | Status: UNKNOWN